"The most advanced neurosurgery technology to provide world-class pain relief."

During the past decade, Barolat Neuroscience conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Barolat Neuroscience" are "Chronic Pain" (2 trials). Many other conditions were trialed in "Barolat Neuroscience" in a lesser frequency.

Most popular intervention types in "Barolat Neuroscience" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Boston Scientific Systems" (1 trials), "Non Boston Scientific Systems" (1 trials) and "Precision Spectra™ SCS system programming features" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barolat Neuroscience" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Barolat Neuroscience". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Barolat Neuroscience, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barolat Neuroscience, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".